Exencial Wealth Advisors LLC boosted its holdings in Centene Corp (NYSE:CNC) by 89.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,110 shares of the company’s stock after buying an additional 8,528 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in Centene were worth $962,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Huntington National Bank raised its holdings in Centene by 110.7% during the 1st quarter. Huntington National Bank now owns 472 shares of the company’s stock worth $25,000 after purchasing an additional 248 shares during the last quarter. Toth Financial Advisory Corp raised its holdings in Centene by 100.0% during the 1st quarter. Toth Financial Advisory Corp now owns 480 shares of the company’s stock worth $25,000 after purchasing an additional 240 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new position in Centene during the 1st quarter worth approximately $27,000. Shamrock Asset Management LLC raised its holdings in Centene by 100.0% during the 1st quarter. Shamrock Asset Management LLC now owns 522 shares of the company’s stock worth $28,000 after purchasing an additional 261 shares during the last quarter. Finally, Lindbrook Capital LLC bought a new position in Centene during the 4th quarter worth approximately $31,000. Institutional investors and hedge funds own 49.14% of the company’s stock.
NYSE:CNC opened at $57.14 on Wednesday. The firm has a market capitalization of $22.93 billion, a PE ratio of 16.14, a P/E/G ratio of 0.95 and a beta of 1.21. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. Centene Corp has a twelve month low of $45.44 and a twelve month high of $74.49.
Several research analysts have issued reports on the stock. Zacks Investment Research lowered shares of Centene from a “buy” rating to a “hold” rating in a report on Friday, May 17th. ValuEngine lowered shares of Centene from a “sell” rating to a “strong sell” rating in a report on Thursday, April 18th. Cowen reiterated a “buy” rating and issued a $77.00 price objective on shares of Centene in a research note on Sunday, March 31st. Cantor Fitzgerald reiterated a “buy” rating and issued a $83.00 price objective on shares of Centene in a research note on Sunday, April 21st. Finally, Credit Suisse Group lowered their price objective on shares of Centene from $76.00 to $63.00 and set a “neutral” rating for the company in a research note on Friday, March 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seventeen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $75.80.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Read More: Special Dividends
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corp (NYSE:CNC).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.